sglt2 inhibitors and glp-1 receptor agonists Combining in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors and GLP-1 Receptor

Persistent metabolic adaptation 6 years after The Biggest Loser competition

Kosowska A, Gallego-Colon E, Garczorz W, Klych-Ratuszny A, Aghdam MR, Woz Niak M, et al

Studies suggest it may support weight loss of around 1.5-2 kg (3-5 pounds) over 12-16 weeks

SURPASS-CVOT compared once-weekly tirzepatide with dulaglutide in adults with type 2 diabetes and high cardiovascular risk, showing a 9% relative risk reduction in MACE (HR 0.92, 95% CI 0.83 to 1.01)

Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation

Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women